Herbert J Conrad's Net Worth
$5.73 Million
Who is Herbert J Conrad?
Herbert J Conrad has an estimated net worth of $5.73 Million. This is based on reported shares across multiple companies, which include SAVIENT PHARMACEUTICALS INC, TEKMIRA PHARMACEUTICALS CORP, Celldex Therapeutics, Inc., Matinas BioPharma Holdings, Inc., Pharmasset Inc, and BONE CARE INTERNATIONAL INC.
SEC CIK
Herbert J Conrad's CIK is 0001218815
Past Insider Trading and Trends
2007 was Herbert J Conrad's most active year for acquiring shares with 15 total transactions. Herbert J Conrad's most active month to acquire stocks was the month of May. 2007 was Herbert J Conrad's most active year for disposing of shares, totalling 22 transactions. Herbert J Conrad's most active month to dispose stocks was the month of September. 2004 saw Herbert J Conrad paying a total of $551,093.93 for 44,673 shares, this is the most they've acquired in one year. In 2005 Herbert J Conrad cashed out on 103,424 shares for a total of $2,286,768.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SAVIENT PHARMACEUTICALS INC No price found
InvestorHerbert J Conrad owns 28,501 units of Common stock, $.01 par value per share. From 2003 to 2007 Herbert J Conrad acquired a total of 104,658 shares in SAVIENT PHARMACEUTICALS INC at a cost of $671,001.83, Herbert also disposed a total of 85,000 shares of SAVIENT PHARMACEUTICALS INC equalling to $1,585,653.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.06% | 3.51K |
$11.38 | $39,989.32 | 28.5K |
Jun 8
| |||
Form 4
| +42.47% | 7.45K |
$5.37 | $39,995.76 | 24.99K |
May 5
| |||
Form 4
| +10.19% | 1.62K |
$24.66 | $39,998.52 | 17.54K |
May 13
| |||
Form 4
|
—
|
0
|
$13.22 | -$214,125.00 | 15.92K |
May 2 - May 6
| |||
Form 4
| -38.58% | -10.00K |
$9.05 | -$221,770.50 | 15.92K |
Apr 1 - Apr 2
| |||
Form 4
|
—
|
0
|
$13.86 | -$180,600.00 | 25.92K |
Mar 3 - Mar 4
| |||
Form 4
|
—
|
0
|
$11.67 | -$159,665.00 | 25.92K |
Feb 1 - Feb 4
| |||
Form 4
|
—
|
0
|
$13.50 | -$208,395.00 | 25.92K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
$13.33 | -$16,275.00 | 25.92K |
Nov 28 - Nov 30
| |||
Form 4
|
—
|
0
|
$13.46 | -$16,485.00 | 25.92K |
Oct 10
| |||
Form 4
|
—
|
0
|
$11.48 | -$97,065.00 | 25.92K |
Oct 5 - Oct 9
| |||
Form 4
|
—
|
0
|
$11.70 | -$19,112.50 | 25.92K |
Oct 3
| |||
Form 4
| +14.47% | 3.28K |
$12.77 | $41,847.29 | 25.92K |
May 15
| |||
Form 4
| +1.39% | 311 |
$12.02 | $3,738.22 | 22.64K |
Mar 30
| |||
Form 4/A
| +1.52% | 334 |
$11.21 | $3,744.14 | 22.33K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
| +2.69% | 576 |
$6.51 | $3,749.76 | 22K |
Sep 29
| |||
Form 4/A
| +3.45% | 714 |
$5.25 | $3,748.50 | 21.42K |
Jun 30
| |||
Form 4
| +3.45% | 714 |
$5.25 | $3,748.50 | 21.42K |
Jun 30
| |||
Form 4
| +3.51% | 703 |
$5.33 | $3,746.99 | 20.7K |
Mar 31
| |||
Form 4
| +5.27% | 1K |
$3.74 | $3,747.48 | 20K |
Dec 30
| |||
Form 4
| +5.52% | 994 |
$3.77 | $3,747.38 | 19K |
Sep 30
| |||
Form 4
| +4.95% | 850 |
$4.41 | $3,748.50 | 18.01K |
Jun 30
| |||
Form 4
| +8.84% | 1.39K |
$2.69 | $3,749.86 | 17.16K |
Mar 31
| |||
Form 4
| +9.62% | 1.38K |
$2.71 | $3,747.93 | 15.76K |
Dec 31
| |||
Form 4
| +12.79% | 1.63K |
$2.30 | $3,749.00 | 14.38K |
Sep 30
| |||
Form 4
| +8.59% | 1.01K |
$2.48 | $2,499.84 | 12.75K |
Jun 30
| |||
Form 4
| +5.88% | 652 |
$3.83 | $2,497.16 | 11.74K |
Mar 31
| |||
Form 4
| +5.14% | 542 |
$4.61 | $2,498.62 | 11.09K |
Dec 31
| |||
Form 4/A
| +4.92% | 495 |
$5.05 | $2,499.75 | 10.55K |
Sep 30
| |||
Form 4
| +4.92% | 495 |
$4.14 | $2,049.30 | 10.55K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TEKMIRA PHARMACEUTICALS CORP (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $44
InvestorHerbert J Conrad owns 28,500 units of Common Stock which is worth $1,254,000.00 and 38,500 units of Common Stock, par value $0.001 per share which is worth $1,694,000.00. From 2008 to 2024 Herbert J Conrad acquired a total of 38,500 shares in Celldex Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +35.09% | 10K |
—
|
—
| 38.5K |
Jun 15
| |||
Form 4
| +54.05% | 10K |
—
|
—
| 28.5K |
Jun 8
| |||
Form 4
| +54.17% | 6.5K |
—
|
—
| 18.5K |
Jun 10
| |||
Form 4
| +20.00% | 2K |
—
|
—
| 12K |
Jun 4
| |||
Form 4
| +25.00% | 2K |
—
|
—
| 10K |
Jun 19
| |||
Form 4
| +33.33% | 2K |
—
|
—
| 8K |
Jun 20
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Sep 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $3.45
InvestorHerbert J Conrad owns 122,019 units of Common Stock which is worth $420,965.55. Herbert J Conrad used to own units in Common Stock, par value $0.0001 per share but no longer holds any shares there. In the year 2017 Herbert J Conrad filed a total of 26 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.69M |
Aug 4 - Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.2M |
Jul 7
| |||
Form 4
| +18.17% | 240K |
—
|
—
| 1.56M |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
| 1.82M |
Jan 13 - May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +5.83% | 30K |
—
|
—
| 544.62K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
| 2.76M |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
| 3.91M |
May 13
| |||
Form 4
| +2.10% | 10.57K |
—
|
—
| 514.62K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +154.59% | 306.07K |
—
|
—
| 504.05K |
Jul 29 - Sep 30
| |||
Form 4
| +16.48% | 28K |
—
|
—
| 197.98K |
Jun 30
| |||
Form 4
| +16.90% | 25K |
$0.96 | $24,115.00 | 172.96K |
May 16
| |||
Form 4
| +22.02% | 22.02K |
—
|
—
| 122.02K |
Mar 31
| |||
Form 4
| -97.52% | -3.93M |
—
|
—
| 100K |
Feb 8
| |||
Form 4
| +1.01% | 40.34K |
—
|
—
| 4.03M |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +0.66% | 26.09K |
—
|
—
| 3.99M |
Oct 1
| |||
Form 4
| +1.41% | 55.3K |
—
|
—
| 3.97M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +0.81% | 31.58K |
—
|
—
| 3.91M |
Mar 30
| |||
Form 4
| +2.65% | 100K |
$1.30 | $130,000.00 | 3.88M |
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pharmasset Inc No price found
InvestorHerbert J Conrad owns 2,000 units of Common Stock, $.001 par value per share. In the year 2008 Herbert J Conrad filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 2K |
—
|
—
| 2K |
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||